NASDAQ:LGND
Ligand Pharmaceuticals Incorporated Stock News
$86.40
+1.49 (+1.75%)
At Close: May 24, 2024
These 10 highly shorted stocks are soaring as Reddit traders wage war against top Wall Street hedge funds
01:13pm, Wednesday, 27'th Jan 2021
An extreme level of herd mentality led by Reddit's 3 million member strong WallStreetBets forum has sparked an epic rally in the most shorted stocks in the market. The forum, members of which refer to
WallStreetBets: The Big Short-Squeeze
06:49pm, Tuesday, 26'th Jan 2021
WallStreetBets: The Big Short-Squeeze
Ligand's Fourth Quarter Financial Results to be Reported February 3rd
08:30am, Wednesday, 20'th Jan 2021
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report fourth quarter 2020 financial results on February 3, 2021. Ligand's CEO Joh
Ligand Receives Milestone Payment from Merck
08:30am, Wednesday, 13'th Jan 2021
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported that the company will receive a $1.5 million milestone payment from Merck triggered by the U.S. Food and D
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today a collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline (GSK) to levera
Ligand: Scalable Growth
07:23am, Friday, 04'th Dec 2020
Ligand has an interesting business plan that it is executing well. Ligand has three technologies that it calls out as important for its near- to mid-term success.
Ligand (LGND) Up 3.4% Since Last Earnings Report: Can It Continue?
11:30am, Sunday, 29'th Nov 2020
Ligand (LGND) reported earnings 30 days ago. What's next for the stock?
Ligand Announces Clinical and Regulatory Progress by Multiple Partners with OmniAb® Antibodies
08:30am, Monday, 23'rd Nov 2020
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces clinical and regulatory progress by multiple partners utilizing antibodies from its OmniAb® discovery platform
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2020 Results - Earnings Call Transcript
03:59pm, Friday, 30'th Oct 2020
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2020 Results - Earnings Call Transcript
Recap: Ligand Pharmaceuticals Q3 Earnings
08:24am, Friday, 30'th Oct 2020
Shares of Ligand Pharmaceuticals (NASDAQ:LGND) were flat in pre-market trading after the company reported Q3 results.
Ligand Reports Third Quarter 2020 Financial Results
08:00am, Friday, 30'th Oct 2020
SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three- and nine-months ending September 30, 2020 and provided an operating forec
4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)
08:09am, Monday, 26'th Oct 2020
Timothy P. Lynch's Stonepine Capital is a life science-focused hedge fund that seeks to utilize its industry experience to uncover undervalued and under-the-radar health companies. The fund takes a lo
Ligand Acquisitions, And Other News: The Good, Bad And Ugly Of Biopharma
02:16pm, Monday, 14'th Sep 2020
Ligand inks deal to acquire Taurus and xCella Biosciences. Zogenix reports positive data from pivotal Phase 3 clinical trial.
How To Predict Sales Growth
03:23pm, Tuesday, 08'th Sep 2020
I've found seven factors that correlate highly with future sales growth; this article explains each one.
Merger Arbitrage Mondays - Rosetta Stone Acquired At A Huge Premium
02:24pm, Monday, 07'th Sep 2020
Merger activity increased last week with four new deals announced. The acquisition of Rosetta Stone by Cambium Learning Group.
